Abstract Pasteurella multocida (P. multocida) is an aerobic Gram-negative coccobacillus, which is found as part of the natural oral flora of many animals, including most healthy cats and dogs. However, it can cause a variety of infections in humans, usually as a result of the patient being bitten or scratched by a cat or dog. There have been 22 reported cases of P. multocida peritonitis in patients undergoing peritoneal dialysis (PD). Of these, 66.7 % occurred within 12 months of the initiation of PD. Only two cases (11.1 %) developed more than 60 months after the commencement of PD. We report a case of P. multocida peritonitis involving a 45-year-old patient who had been undergoing continuous ambulatory peritoneal dialysis (CAPD) for 84 months without a previous history of peritonitis, who developed P. multocida peritonitis associated with a domestic cat on the very night on which he began using an automated cycler device to switch from CAPD to continuous cyclic peritoneal dialysis (CCPD). Patients maintained on PD who keep pets such as cats or dogs at home should be educated about the risk of developing peritonitis related to their domestic pets, and this warning should be repeated when such patients switch from CAPD to CCPD. Physicians should consider using empiric therapy to prevent P. multocida in pet-owning PD patients who present with a history of PD fluid leakage and peritonitis, especially in patients who use cycler devices.
Introduction
Peritonitis in patients undergoing peritoneal dialysis (PD) is a major cause of hospitalization, transfer to hemodialysis, and catheter removal. Staphylococcus epidermidis and S. aureus are the major pathogens implicated in PD peritonitis [1] . However, Pasteurella multocida (P. multocida) is a rare cause of peritonitis in PD patients.
Pasteurella multocida is a small aerobic Gram-negative coccobacillus found in the oropharynges of many animals, such as cats (50-90 %) and dogs (50-66 %) [2] . Worldwide, 22 cases of PD-associated P. multocida peritonitis have been reported to date , and in Japan, there have been only two cases [13, 23] .
We report a patient who remained peritonitis-free during 84 months of PD who suffered from P. multocida peritonitis associated with a domestic cat on the very night on which he began to use an automated cycler device, together with a review of the literature.
Case report
A 45-year-old man who developed end-stage renal failure after IgA nephropathy had been maintained on continuous ambulatory peritoneal dialysis (CAPD) without developing peritonitis for 84 months. However, on the first night on which he used an automated cycler device to switch from CAPD to continuous cyclic peritoneal dialysis (CCPD) because of a decline of residual renal function, he became aware of dialysate leakage from the PD solution bag.
He immediately disconnected himself from the automated peritoneal dialysis (APD) system and drained the dialysis fluid using the twin-bag system, before filling the peritoneal cavity with new solution. When he exchanged his dialysate the next morning, he noted that his effluent was cloudy. Shortly afterwards, abdominal pain developed, and he visited our hospital and was admitted.
On physical examination, he had a temperature of 38.9°C, a pulse rate of 84 beats/min, a respiratory rate of 16 breaths/min, and a blood pressure value of 110/72 mmHg. His abdomen was diffusely tender and displayed rebound tenderness. His exit site and catheter tunnel showed no evidence of infection. There was no lymphadenopathy noted, which would suggest a complication of cat-scratch disease.
His laboratory data on admission showed a white blood cell (WBC) count of 12400/mm 3 , with 82 % segmented neutrophils, and a C-reactive protein level of 1.20 mg/dl. An analysis of his turbid dialysis fluid found a cell count of 3370 WBC/mm 3 , with 86 % neutrophils. Gram staining of the dialysis fluid was negative. Samples of his dialysate were collected in blood culture bottles. No blood cultures were obtained. The patient was treated under a suspicion of peritonitis of unknown origin and received 1 g vancomycin (VCM) i.v. once and intraperitoneal ceftazidime (CAZ) 1 g (with a 6-h dwell time) as an empirical treatment. On the second admission day, an analysis of his peritoneal fluid demonstrated an increased WBC count of 9220/mm 3 , with 91 % neutrophils, but his symptoms improved rapidly 48 h later. On the fifth admission day, an analysis of his dialysate revealed that his total WBC count had decreased to 107/mm 3 (53 % neutrophils). The final culture results indicated that the organism was P. multocida. The isolated organism was sensitive to ampicillin, piperacillin, cefazolin, cefotiam, CAZ, levofloxacin, gentamicin, and imipenem. VCM was discontinued. The patient was switched to oral levofloxacin (200 mg/day) after 7 days of intraperitoneal CAZ treatment. There was no evidence of a decrease of peritoneal function nor ultrafiltration failure by this peritonitis episode.
The patient reported that he owned two domestic cats that were free to enter his bedroom before he started PD.
Discussion
Peritonitis remains a leading complication in PD patients. In addition, severe and prolonged peritonitis leads to peritoneal membrane failure and is a major cause of PD discontinuation and switching to hemodialysis. Therefore, preventing peritonitis is one of the most important considerations for PD patients and medical staff. Most episodes of PD-related peritonitis are caused by organisms that colonize human skin, such as S. epidermidis and S. aureus, via touch contamination or PD technique failure. In addition, a wide variety of other organisms can cause PDrelated peritonitis. However, P. multocida is a rare cause of PD-related peritonitis, and only 22 cases of PD-related peritonitis involving P. multocida have been reported to date (Table 1) .
P. multocida is an aerobic Gram-negative coccobacillus, which is found as part of the natural oral flora of many animals, including most healthy cats (50-90 %) and dogs (50-66 %), and approximately 20 % of cats have Pasteurella species on their claws [2, 23] .
Almost all reported cases of peritonitis complications associated with this pathogen were due to puncturing of the dialysis tubing by cats or close contact with cats. Only one reported case of P. multocida peritonitis was due to contact with dogs [20] .
It is worth noting that, although the majority of patients on PD use CAPD, most of the reported cases (77.3 %) involved patients using a cycler device, such as CCPD or nightly intermittent peritoneal dialysis (NIPD). It is also possible that the trembling of the dialysis tube and the sound produced by the pump make the cycler device an attractive toy for cats.
In our case, the patient had remained healthy without any episodes of peritonitis during the 84 months in which he had been undergoing PD, in spite of the fact that he owned two cats. We got the impression that he took great care with his personal hygiene and dialysis procedure, and that he took appropriate measures to protect against peritonitis.
However, he developed peritonitis associated with P. multocida on the first day on which he used the cycler device. This episode suggests that using a cycler device is a major risk for cat-associated PD peritonitis.
In a review of P. multocida peritonitis, the period from the initiation of PD to the onset of peritonitis was found to be \12 months in most cases (66.7 % of 18 cases), and it only occurred after more than 60 months in two cases (11.1 %). Therefore, our case was considered to be representative of this rare condition.
There was evidence of PD fluid leakage in 50 % of cases. PD patients using a cycler device who also own a cat might need to be started on antibiotic therapy in order to protect against this organism, even if there is no evidence of leakage.
In our review of the literature, 20 of 22 cases recovered from peritonitis without catheter removal. P. multocida is susceptible to many kinds of antibiotic agent that affect Gram-negative organisms.
Empiric antibiotic combination therapy for PD-related peritonitis affects not only Gram-positive but also Gramnegative organisms. Therefore, empirical therapy involving antibiotics for Gram-negative bacteria might affect P. multocida too. In 11 of 23 cases, including our case, VCM was administered at the initiation of treatment, but was discontinued after Gram-negative bacilli were found by Gram staining or P. multocida was identified in peritoneal dialysate cultures. Gentamicin was the most frequently used antibiotic (11 cases) and was effective in each case. CAZ was used in five cases, including our case, and was effective in four cases. However, it was ineffective in one case. In this case, the treatment was changed from CAZ to piperacillin/tazobactam. Finally, ampicillin was found to be effective, and then the patient recovered. In the latest two reports (9.1 %), it was necessary to transfer the patient to an intensive care unit, as they had developed sepsis [21, 22] . The two cases were improved by changing them to appropriate antibiotic therapy and PD catheter removal. Pasteurella species might be penicillin-resistant because they produce b-lactamase; therefore, ampicillin/sulbactam, piperacillin/tazobactam, and amoxicillin/clavulanate are recommended for the treatment of P. multocida [24, 25] . Patients that display cloudy effluent after being treated with appropriate antibiotics for 5 days have refractory peritonitis and should have their catheter removed [26] .
In conclusion, P. multocida peritonitis is rare in PD patients, and only 22 such cases have been reported. Its transmission almost always involves a cat biting or scratching the PD tubing or bags.
Patients maintained on PD who keep pets such as cats or dogs at home should be educated about the possibility of developing peritonitis related to their domestic pets. When these patients switch from CAPD to CCPD, they should be given information about the risk of pet-associated peritonitis.
Physicians should consider empiric therapy against P. multocida in pet-owning PD patients who present with a history of PD fluid leakage and peritonitis, especially in patients who use cycler devices.
